Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Product
2.3.2 Market Size By Cancer Type
2.3.3 Market Size By End-Use
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Treatment Cost & Pricing Trends
4.1.1 Overview
4.1.2 Average Cost of Precision Oncology Therapies by Cancer Type
4.1.3 Cost Comparison: Targeted Therapy vs. Immunotherapy vs. Chemotherapy
4.1.4 Reimbursement & Insurance Coverage Ratios by Region
4.1.5 Patient Out-of-Pocket Expenditure Trends
4.2 Patient & Demographic Insights
4.2.1 Overview
4.2.2 Number of Cancer Patients Eligible for Precision Oncology (Global & Regional)
4.2.3 Adoption Rates by Age Group & Gender
4.2.4 Patient Willingness-to-Pay for Personalized Treatment
4.2.5 Ratio of Early vs. Late-Stage Patients Receiving Precision Oncology
4.3 Genomic & Biomarker Data Statistics
4.3.1 Overview
4.3.2 Number of Patients Undergoing Genomic Sequencing Annually
4.3.3 Frequency of Biomarker Testing in Oncology Cases
4.3.4 Database Growth of Genomic Profiles (Public & Private)
4.3.5 Biomarker-Linked Therapy Success Rates
4.4 Clinical Trials & Research Insights
4.4.1 Overview
4.4.2 Number of Ongoing Clinical Trials in Precision Oncology
4.4.3 Distribution of Trials by Therapy Type (Targeted, Immunotherapy, Cell-Based)
4.4.4 Average Trial Enrollment Size & Success Rates
4.4.5 Investment Trends in Translational Research & Clinical Pipelines
4.5 Technology Adoption Metrics
4.5.1 Overview
4.5.2 Penetration of Next-Generation Sequencing (NGS) in Oncology Diagnostics
4.5.3 Use of AI & Big Data in Precision Oncology Treatment Planning
4.5.4 Digital Pathology & Imaging Integration Rates
4.5.5 Adoption of Companion Diagnostics Across Regions
5. Precision Oncology Market Segmental Analysis & Forecast, By Product, 2021 – 2032, Value (Usd Billion)
5.1 Introduction
5.2 Diagnostics
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Therapeutics
6. Precision Oncology Market Segmental Analysis & Forecast, By Cancer Type, 2021 – 2032, Value (Usd Billion)
6.1 Introduction
6.2 Breast Cancer
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Colorectal Cancer
6.4 Cervical Cancer
6.5 Prostate Cancer
6.6 Lung Cancer
6.7 Others
7. Precision Oncology Market Segmental Analysis & Forecast, By End-Use, 2021 – 2032, Value (Usd Billion)
7.1 Introduction
7.2 Hospitals & Diagnostic Laboratories
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Pharmaceutical & Biotechnology Companies
7.4 Healthcare Data Companies
8. Precision Oncology Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (Usd Billion)
8.1 Introduction
8.2 North America
8.2.1 Key Trends
8.2.2 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.2.3 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.2.4 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.2.5 Precision Oncology Market Size & Forecast, By Country, 2021 – 2032
8.2.5.1 USA
8.2.5.1.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.2.5.1.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.2.5.1.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.2.5.2 Canada
8.2.5.2.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.2.5.2.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.2.5.2.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.3 Europe
8.3.1 Key Trends
8.3.2 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.3.3 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.3.4 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.3.5 Precision Oncology Market Size & Forecast, By Country, 2021 – 2032
8.3.5.1 Germany
8.3.5.1.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.3.5.1.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.3.5.1.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.3.5.2 UK
8.3.5.2.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.3.5.2.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.3.5.2.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.3.5.3 France
8.3.5.3.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.3.5.3.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.3.5.3.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.3.5.4 Italy
8.3.5.4.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.3.5.4.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.3.5.4.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.3.5.5 Spain
8.3.5.5.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.3.5.5.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.3.5.5.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.3.5.6 Russia
8.3.5.6.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.3.5.6.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.3.5.6.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.3.5.7 Poland
8.3.5.7.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.3.5.7.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.3.5.7.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.3.5.8 Rest of Europe
8.3.5.8.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.3.5.8.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.3.5.8.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.4 Asia-Pacific
8.4.1 Key Trends
8.4.2 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.4.3 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.4.4 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.4.5 Precision Oncology Market Size & Forecast, By Country, 2021 – 2032
8.4.5.1 China
8.4.5.1.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.4.5.1.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.4.5.1.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.4.5.2 India
8.4.5.2.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.4.5.2.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.4.5.2.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.4.5.3 Japan
8.4.5.3.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.4.5.3.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.4.5.3.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.4.5.4 South Korea
8.4.5.4.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.4.5.4.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.4.5.4.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.4.5.5 Australia
8.4.5.5.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.4.5.5.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.4.5.5.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.4.5.6 ASEAN Countries
8.4.5.6.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.4.5.6.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.4.5.6.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.4.5.7 Rest of Asia-Pacific
8.4.5.7.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.4.5.7.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.4.5.7.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.5 Latin America
8.5.1 Key Trends
8.5.2 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.5.3 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.5.4 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.5.5 Precision Oncology Market Size & Forecast, By Country, 2021 – 2032
8.5.5.1 Brazil
8.5.5.1.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.5.5.1.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.5.5.1.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.5.5.2 Argentina
8.5.5.2.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.5.5.2.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.5.5.2.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.5.5.3 Mexico
8.5.5.3.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.5.5.3.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.5.5.3.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.5.5.4 Colombia
8.5.5.4.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.5.5.4.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.5.5.4.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.5.5.5 Rest of Latin America
8.5.5.5.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.5.5.5.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.5.5.5.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.6 Middle East & Africa
8.6.1 Key Trends
8.6.2 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.6.3 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.6.4 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.6.5 Precision Oncology Market Size & Forecast, By Country, 2021 – 2032
8.6.5.1 UAE
8.6.5.1.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.6.5.1.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.6.5.1.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.6.5.2 Saudi Arabia
8.6.5.2.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.6.5.2.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.6.5.2.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.6.5.3 Qatar
8.6.5.3.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.6.5.3.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.6.5.3.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.6.5.4 Egypt
8.6.5.4.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.6.5.4.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.6.5.4.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.6.5.5 South Africa
8.6.5.5.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.6.5.5.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.6.5.5.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
8.6.5.6 Rest of Middle East & Africa
8.6.5.6.1 Precision Oncology Market Size & Forecast, By Product, 2021 – 2032
8.6.5.6.2 Precision Oncology Market Size & Forecast, By Cancer Type, 2021 – 2032
8.6.5.6.3 Precision Oncology Market Size & Forecast, By End-Use, 2021 – 2032
9. Competitive Landscape
9.1 Key Players' Positioning
9.2 Competitive Developments
9.2.1 Key Strategies Adopted (%), By Key Players, 2024
9.2.2 Year-Wise Strategies & Development, 2021 – 2025
9.2.3 Number Of Strategies Adopted By Key Players, 2024
9.3 Market Share Analysis, 2024
9.4 Product/Service & Application Benchmarking
9.4.1 Product/Service Specifications & Features By Key Players
9.4.2 Product/Service Heatmap By Key Players
9.4.3 Application Heatmap By Key Players
9.5 Industry Start-Up & Innovation Landscape
9.6 Key Company Profiles
9.6.1 Thermo Fisher Scientific Inc.
9.6.1.1 Company Overview & Snapshot
9.6.1.2 Product/Service Portfolio
9.6.1.3 Key Company Financials
9.6.1.4 SWOT Analysis
9.6.2 Invitae Corporation
9.6.3 Qiagen N.V.
9.6.4 Illumina, Inc.
9.6.5 Laboratory Corporation of America Holding
9.6.6 Exact Sciences Corporation
9.6.7 Rain Oncology Inc.
9.6.8 Strata Oncology, Inc.
9.6.9 Xilis, Inc.
9.6.10 Variantyx, Inc.
9.6.11 Bioserve
9.6.12 Relay Therapeutics
9.6.13 Acrivon Therapeutics
9.6.14 Foundation Medicine, Inc.
9.6.15 Guardant Health, Inc.
9.6.16 Nanostring Technologies, Inc.
9.6.17 Caris Life Sciences
9.6.18 Bio-Rad Laboratories, Inc.
9.6.19 Freenome Holdings, Inc.
9.6.20 Tempus Labs, Inc.
10. Analyst Recommendations
10.1 SNS Insider Opportunity Map
10.2 Industry Low-Hanging Fruit Assessment
10.3 Market Entry & Growth Strategy
10.4 Analyst Viewpoint & Suggestions On Market Growth
11. Assumptions
12. Disclaimer
13. Appendix
13.1 List Of Tables
13.2 List Of Figures
